
XII Medical
Provides minimally invasive technology for obstructive sleep apnea.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor investor investor investor investor investor | €0.0 | round | |
* | $45.0m | Series B | |
Total Funding | 000k |
Related Content
XII Medical is a healthcare technology company focused on developing minimally invasive solutions for the treatment of obstructive sleep apnea (OSA). The company targets patients suffering from OSA, a condition that significantly increases the risk of premature death and cardiovascular issues. Operating within the medical device market, XII Medical leverages clinical research and technical expertise from the Cleveland Clinic to create patient-centered therapies. The business model revolves around the development and commercialization of advanced medical technologies designed to improve patient outcomes. Revenue is generated through the sale of these specialized medical devices to healthcare providers and institutions.
Keywords: obstructive sleep apnea, minimally invasive, healthcare technology, patient-centered, Cleveland Clinic, medical devices, clinical research, cardiovascular risk, sleep disorder, advanced therapies.